Small nucleolar RNAs (snoRNAs), a distinct class of noncoding RNAs, encompass highly diverse structures and have a range of 60 to 300 nucleotides in length. About 90% of human snoRNAs are intronic and embedded within introns of their host gene transcripts. Most snoRNAs enriched in specific tissue correlate in abundance with their parental host genes. Advancements in high-throughput sequencing have facilitated the discovery of dysregulated snoRNA expression in numerous human malignancies including head and neck squamous cell carcinoma (HNSCC). Hundreds of differentially expressed snoRNAs have been identified in HNSCC tissues. Among 1,524 snoRNA genes in a 567 HNSCC cohort, 113 snoRNAs were found to be survival related. As for snoRNA’s roles in HNSCC, based on the available evidence, dysregulated snoRNAs are closely associated with the carcinogenesis and development of HNSCC. Upregulated snoRNAs have been shown to augment the expression of other oncogenes or activate the Wnt/β-catenin signaling pathway, thereby promoting tumor cell viability, glycolysis, migration, and the epithelial-mesenchymal transition while inhibiting apoptosis in vitro. In vivo animal studies have further elucidated the functional roles of snoRNAs. Knockdown of host genes of these snoRNAs suppressed the Wnt/β-catenin signaling pathway and restrained tumor proliferation and aggressiveness in mice. The putative mechanisms underlying these observations are associated with the biological functions of snoRNAs, primarily involving microRNA-like functions through the generation of microRNA-like fragments and regulation of alternative splicing to yield diverse transcripts. While most of the snoRNAs are upregulated in HNSCC, 4 downregulated snoRNAs have been identified and annotated. SNORA36B (implicated in the regulation of DNA templates) and U3 (chr17, influencing cell proliferation) may serve as protective factors associated with prolonged overall survival. This review describes the viable structures of snoRNAs, endeavors to refine snoRNA sequencing technology, and summarizes snoRNAs’ expression profile as well as their role in HNSCC progression for potential diagnostic and therapeutic strategies for HNSCC management.
BergeronDParaqindesHFafard-CoutureÉDeschamps-FrancoeurGFaucher-GiguèreLBouchard-BourellePAbou ElelaSCatezFMarcelVScottMS. 2023. SnoDB 2.0: an enhanced interactive database, specializing in human snoRNAs. Nucleic Acids Res. 51(D1):D291–D296.
2.
BoivinVReuletGBoisvertOCoutureSElelaSAScottMS. 2020. Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA. Nucleic Acids Res. 48(5):2271–2286.
3.
CaoTRajasinghSSamantaSDawnBBittelDCRajasinghJ.2018. Biology and clinical relevance of noncoding sno/scaRNAs. Trends Cardiovasc Med. 28(2):81–90.
4.
ChallakkaraMFChhabraR.2023. SnoRNAs in hematopoiesis and blood malignancies: a comprehensive review. J Cell Physiol. 238(6):1207–1225.
5.
Chamorro-PetronacciCPerez-SayánsMPadín-IruegasMEMarichalar-MendiaXGallas-TorreiraMGarcía GarcíaA.2018. Differential expression of snoRNAs in oral squamous cell carcinomas: new potential diagnostic markers. J Enzyme Inhib Med Chem. 33(1):424–427.
6.
ChenSLiQHChenXBaoHJWuWShenFLuBFJiangRQZongZHZhaoY.2022. SNORA70E promotes the occurrence and development of ovarian cancer through pseudouridylation modification of RAP1B and alternative splicing of PARPBP. J Cell Mol Med. 26(20):5150–5164.
DeryushevaSGallJG. 2019. Small, smaller, smallest: minimal structural requirements for a fully functional box C/D modification guide RNA. Biomolecules. 9(9):457.
9.
Deschamps-FrancoeurGBoivinVAbou ElelaSScottMS. 2019. CoCo: RNA-seq read assignment correction for nested genes and multimapped reads. Bioinformatics. 35(23):5039–5047.
10.
Deschamps-FrancoeurGCoutureSAbou-ElelaSScottMS. 2022. The snoGloBe interaction predictor reveals a broad spectrum of C/D snoRNA RNA targets. Nucleic Acids Res. 50(11):6067–6083.
11.
DsouzaVLAdigaDSriharikrishnaaSSureshPSChatterjeeAKabekkoduSP. 2021. Small nucleolar RNA and its potential role in breast cancer—a comprehensive review. Biochim Biophys Acta Rev Cancer. 1875(1):188501.
Fafard-CoutureÉBergeronDCoutureSAbou-ElelaSScottMS. 2021. Annotation of snoRNA abundance across human tissues reveals complex snoRNA-host gene relationships. Genome Biol. 22(1):172.
17.
GanotPCaizergues-FerrerMKissT.1997. The family of box ACA small nucleolar RNAs is defined by an evolutionarily conserved secondary structure and ubiquitous sequence elements essential for RNA accumulation. Genes Dev. 11(7):941–956.
18.
GongJLiYLiuCJXiangYLiCYeYZhangZHawkeDHParkPKDiaoL, et al. 2017. A pan-cancer analysis of the expression and clinical relevance of small nucleolar RNAs in human cancer. Cell Rep. 21(7):1968–1981.
19.
JiaYChenXZhaoDMaS.2022. SNHG1/miR-194-5p/MTFR1 axis promotes TGFβ1-induced EMT, migration and invasion of tongue squamous cell carcinoma cells. Mol Biotechnol. 64(7):780–790.
20.
KangRYaoDFXuGZZhouYH. 2020. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway. Neoplasma. 67(5):1094–1105.
21.
KissTFayet-LebaronEJádyBE. 2010. Box H/ACA small ribonucleoproteins. Mol Cell. 37(5):597–606.
22.
LanTMaWHongZWuLChenXYuanY.2017. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma. J Exp Clin Cancer Res. 36(1):11.
23.
Lemus-DiazNFerreiraRRBohnsackKEGruberJBohnsackMT. 2020. The human box C/D snoRNA U3 is a miRNA source and miR-U3 regulates expression of sortin nexin 27. Nucleic Acids Res. 48(14):8074–8089.
24.
LiJSunSChenWYuanK.2019. Small nucleolar RNA host gene 12 (SNHG12) promotes proliferation and invasion of laryngeal cancer cells via sponging miR-129-5p and potentiating WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) expression. Med Sci Monit. 25:5552–5560.
25.
LiQXieBChenXLuBChenSShengXZhaoY.2023. SNORD6 promotes cervical cancer progression by accelerating E6-mediated p53 degradation. Cell Death Discov. 9(1):192.
26.
LiuJZhaoCYangSDongC.2020. LncRNA SNHG1 promotes the development of oral cavity cancer via regulating the miR-421/HMGB2 axis. Cell Mol Biol. 66(8):14–19.
27.
LiuXAliMKZhaoLDuaKMaoY.2023. The emerging diagnostic and therapeutic roles of small nucleolar RNAs in lung diseases. Biomed Pharmacother. 161:114519.
28.
LiuXZhangBJiaYFuM.2020. SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression. Cell Cycle. 19(6):711–725.
29.
LiuZTaoH.2020. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma. J Cell Biochem. 121(3):2150–2158.
30.
LuBChenXLiuXChenJQinHChenSZhaoY.2022. C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2′-O-methylation of PARP1. J Transl Med. 20(1):618.
31.
LuNYinYYaoYZhangP.2021. SNHG3/miR-2682-5p/HOXB8 promotes cell proliferation and migration in oral squamous cell carcinoma. Oral Dis. 27(5):1161–1170.
32.
MarnefARichardPPinzónNKissT.2014. Targeting vertebrate intron-encoded box C/D 2′-O-methylation guide RNAs into the Cajal body. Nucleic Acids Res. 42(10):6616–6629.
33.
MohrSGhanemESmithWSheeterDQinYKingOPolioudakisDIyerVRHunicke-SmithSSwamyS, et al. 2013. Thermostable group II intron reverse transcriptase fusion proteins and their use in cDNA synthesis and next-generation RNA sequencing. RNA. 19(7):958–970.
34.
MonzianiAUlitskyI.2023. Noncoding snoRNA host genes are a distinct subclass of long noncoding RNAs. Trends Genet. 39(12):908–923.
35.
PauliCLiuYRohdeCCuiCFijalkowskaDGerloffDWalterCKrijgsveldJDugasMEdemirB, et al. 2020. Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation. Blood. 135(23):2059–2070.
36.
PelczarPFilipowiczW.1998. The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5′-terminal oligopyrimidine gene family. Mol Cell Biol. 18(8):4509–4518.
37.
QiaoCQiaoTYangSLiuLZhengM.2022. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral squamous cell carcinoma. Cancer Gene Ther. 29(1):122–132.
38.
RNAcentral Consortium. 2021. RNAcentral 2021: secondary structure integration, improved sequence search and new member databases. Nucleic Acids Res. 49(D1):D212–D220.
39.
ShiJZhouTChenQ.2022. Exploring the expanding universe of small RNAs. Nat Cell Biol. 24(4):415–423.
40.
TongFGuoJMiaoZLiZ.2021. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis. Cancer Biomark. 30(1):1–12.
41.
TycowskiKTShuMDSteitzJA. 1996. A mammalian gene with introns instead of exons generating stable RNA products. Nature. 379(6564):464–466.
42.
WangLSuKWuHLiJSongD.2019. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis. Life Sci. 232:116597.
43.
World Health Organization Classification of Tumours Editorial Board. 2024. Head and neck tumours: WHO classification of tumours series. In: WHO Classification of Tumours Editorial Board, editor. Lyon (France): IARC Press.
44.
XieFLiuSWangJXuanJZhangXQuLZhengLYangJ.2021. deepBase v3.0: expression atlas and interactive analysis of ncRNAs from thousands of deep-sequencing data. Nucleic Acids Res. 49(D1):D877–D883.
45.
XingLZhangXZhangXTongD.2020. Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer. J Cell Physiol. 235(11):8071–8084.
46.
XingYHYaoRWZhangYGuoCJJiangSXuGDongRYangLChenLL. 2017. SLERT regulates DDX21 rings associated with Pol I transcription. Cell. 169(4):664–678.e616.
47.
YangJHZhangXCHuangZPZhouHHuangMBZhangSChenYQQuLH. 2006. snoSeeker: an advanced computational package for screening of guide and orphan snoRNA genes in the human genome. Nucleic Acids Res. 34(18):5112–5123.
48.
YangYYangYPYiMLHuangFTZhuXHuangGW. 2023. Exploring the expression of SNHG1 and its effect on the PI3K-AKT axis in nasopharyngeal cancer. Neoplasma. 70(5):670–682.
49.
YinYTanYYaoYLuNZhangF.2020. SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma. Oral Dis. 26(8):1631–1639.
50.
YuFBrackenCPPillmanKALawrenceDMGoodallGJCallenDFNeilsenPM. 2015. p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA. PLoS One. 10(6):e0129190.
51.
ZhangMLiKBaiJVan DammeRZhangWAlbaMStilesBLChenJFLuZ.2023. A snoRNA-tRNA modification network governs codon-biased cellular states. Proc Natl Acad Sci U S A. 120(41):e2312126120.
52.
ZhangMLiKBaiJVelemaWAYuCvan DammeRLeeWHCorpuzMLChenJFLuZ.2021. Optimized photochemistry enables efficient analysis of dynamic RNA structuromes and interactomes in genetic and infectious diseases. Nat Commun. 12(1):2344.
53.
ZhangYShangXYuMBiZWangKZhangQXieLSongXSongX.2023. A three-snoRNA signature: SNORD15A, SNORD35B and SNORD60 as novel biomarker for renal cell carcinoma. Cancer Cell Int. 23(1):136.
54.
ZhangYZhaoZHuangLALiuYYaoJSunCLiYZhangZYeYYuanF, et al. 2023. Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metab. 35(8):1457–1473.e13.
55.
ZhenNZhuJMaoSZhangQGuSMaJZhangYYinMLiHHuangN, et al. 2023. Alternative splicing of lncRNAs from SNHG family alters snoRNA expression and induces chemoresistance in hepatoblastoma. Cell Mol Gastroenterol Hepatol. 16(5):735–755.
56.
ZhongFZhouNWuKGuoYTanWZhangHZhangXGengGPanTLuoH, et al. 2015. A SnoRNA-derived piRNA interacts with human interleukin-4 pre-mRNA and induces its decay in nuclear exosomes. Nucleic Acids Res. 43(21):10474–10491.
57.
ZhouZChenY.2023. LncRNA SNHG1 promotes nasopharyngeal carcinoma development via targeting miR-424-5p. Histol Histopathol. 38(8):953–963.
58.
ZouAEKuJHondaTKYuVKuoSZZhengHXuanYSaadMAHintonABrumundKT, et al. 2015. Transcriptome sequencing uncovers novel long noncoding and small nucleolar RNAs dysregulated in head and neck squamous cell carcinoma. RNA. 21(6):1122–1134.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
